Live Breaking News & Updates on Mission covid suraksha

Stay informed with the latest breaking news from Mission covid suraksha on our comprehensive webpage. Get up-to-the-minute updates on local events, politics, business, entertainment, and more. Our dedicated team of journalists delivers timely and reliable news, ensuring you're always in the know. Discover firsthand accounts, expert analysis, and exclusive interviews, all in one convenient destination. Don't miss a beat — visit our webpage for real-time breaking news in Mission covid suraksha and stay connected to the pulse of your community

Omicron: Drug controller gives emergency-use approval to booster vaccine for Omicron variant | India News

India News: NEW DELHI: India's drug controller has granted emergency use authorisation for the Omicron-specific mRNA-based booster vaccine developed by Gennova Bi.

India , Wuhan , Hubei , China , Jitendra-singh , Sanjay-singh , Rajeshs-gokhale , Indian-covid , Gennova-biopharmaceuticals-ltd , Gennova-biopharmaceuticals-under-mission-covid-suraksha , Mission-covid-suraksha , Department-of-biotechnology

Drug controller's nod for Omicron-specific mRNA-based vaccine

India's drug controller has granted emergency use authorisation for the Omicron-specific mRNA-based booster vaccine developed by Genova.

India , Wuhan , Hubei , China , New-delhi , Delhi , Indian-covid , Sanjay-singh , Rajeshs-gokhale , Jitendra-singh , Genova-biopharmaceuticals-under-mission-covid-suraksha , Mission-covid-suraksha

Govt Gives Nod For Covid-19 Omicron-Specific mRNA-Based Vaccine

Govt Gives Nod For Covid-19 Omicron-Specific mRNA-Based Vaccine
outlookindia.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from outlookindia.com Daily Mail and Mail on Sunday newspapers.

Wuhan , Hubei , China , India , Sanjay-singh , Indian-covid , Rajeshs-gokhale , Jitendra-singh , Gennova-biopharmaceuticals-ltd , Mission-covid-suraksha , Vaccine-development-mission , Department-of-biotechnology

India's first mRNA-based Omicron-specific booster vaccine from Pune-based Gennova gets DCGI approval

Gennova Biopharmaceuticals' mRNA Covid-19 booster vaccine, 'Gemcovac Om', has received emergency use authorisation from the office of the Drugs Controller General of India for the Omicron variant. The vaccine is the first booster Covid-19 vaccine developed in India against the highly transmissible Omicron variant and has demonstrated robust immune responses in phase 3 clinical trials. It is stable at two to eight degrees Centigrade and has been developed using Gennova's indigenous platform technology, supported under 'Mission Covid Suraksha'.

India , Pune , Maharashtra , Wuhan , Hubei , China , Sanjay-singh , Samit-mehta , Indian-covid , A-press-information-bureau , Gennova-biopharmaceuticals-ltd , Mission-covid-suraksha

Union Health Minister Launches First Intranasal Covid Vaccine

A rollout of iNCOVACC is expected to begin in private hospitals that have placed advance orders, , Dr Mansukh Mandaviya, union health ministry, Intranasal Covid Vaccine, iNNCOVACC

India , Atmanirbhar-bharat , Mansukh-mandaviya , Jitendra-singh , Union-health , Bharat-biotech-international , Mission-covid-suraksha , Department-of-biotechnology , Biotechnology-industry-research-assistance , Ministry-of-science , Union-health-minister-dr-mansukh-mandaviya , Union-minister

Union Health Minister Dr. Mansukh Mandaviya unveils world's first intranasal COVID19 vaccine, iNNCOVACC - New Delhi Times

Dr. Mansukh Mandaviya, Union Minister of Health & Family Welfare unveiled the iNNCOVACC COVID19 vaccine today in the presence of Union Minister of State (IC) for Science and Technology, Dr Jitendra Singh. iNNCOVACC is the world’s first intranasal COVID19 vaccine to receive approval for the primary 2-dose schedule, and as a heterologous booster dose. It…

India , Atmanirbhar-bharat , Aatmanirbhar-bharat , Mansukh-mandaviya , Jitendra-singh , Union-health , Bharat-biotech-international-limited , Mission-covid-suraksha , Health-family-welfare , Department-of-biotechnology , Biotechnology-industry-research-assistance , Ministry-of-science

India's first intranasal Covid vaccine iNNCOVACC launched

Union Health Minister Mansukh Mandaviya on Thursday unveiled the Covid-19 vaccine, iNNCOVACC in the presence of Union Minister of State (IC) for Science and Technology, Jitendra Singh.iNNCOVACC is the world's first intranasal Covid-19 vaccine ...

India , New-delhi , Delhi , Atmanirbhar-bharat , Jitendra-singh , Union-health , Biotechnology-industry-research-assistance-council , Bharat-biotech-international-limited , Department-of-biotech , Department-of-biotechnology , Ministry-of-science , Union-health-minister-mansukh-mandaviya

Health Minister Mandaviya unveils world's first intranasal Covid vaccine iNNCOVACC

Uniindia: New Delhi, Jan 26 (UNI) Union Minister of Health and Family Welfare Dr. Mansukh Mandaviya on Thursday unveiled the iNNCOVACC Covid-19 vaccine in the presence of Union Minister of State (IC) for Science and Technology Dr Jitendra Singh.

India , New-delhi , Delhi , Rajesh-gokhale , Rajesh-kumar-pathak , Atmanirbhar-bharat , Krishna-ella , Aatmanirbhar-bharat , Jitendra-singh , Suchitra-ella , Union-health , Bharat-biotech-international-limited

'iNCOVACC' can produce three immune responses, no other nasal vaccine in world can produce: Bharat Biotech Chairman Dr Krishna Ella

Bharat Biotech's Chairman and MD Dr Krishna Ella on the launch of the 'iNCOVACC' vaccine said that the vaccine is easy to deliver and doesn't need any syringe or needle.

India , Atmanirbhar-bharat , Aatmanirbhar-bharat , Mansukh-mandaviya , Shri-rajesh-kumar-pathak , Rajesh-gokhale , Narendra-modi , Krishna-ella , Suchitra-ella , Jitendra-singh , Union-health , Bharat-biotech-international-limited

Dr Jitendra lauds 'Team Biotech' for developing world's first Nasal Vaccine - Jammu Kashmir Latest News | Tourism

Excelsior Correspondent NEW DELHI, Jan 22: Union Minister of State (Independent Charge) Science & Technology; Minister of State (Independent Charge) Earth Sciences; MoS PMO, Personnel, Public Grievances, Pensions, Atomic Energy and Space, Dr Jitendra Singh has lauded “Team Biotech” for developing the world’s first Nasal Vaccine. He said, as Minister Incharge Science & Technology, he was proud of the fact that the Department of Biotechnology (DBT) under the Ministry and its PSU, Biotechnology Industry Research Assistance Council (BIRAC) had made […]

India , New-delhi , Delhi , Pune , Maharashtra , Narendra-modi , Atmanirbhar-bharat , Jitendra-singh , Atomic-energy , Incharge-science-technology , Bharat-biotech-international-limited , Mission-covid-suraksha